Peutz-Jeghers syndrome screening: Difference between revisions
No edit summary |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Screening for cancerous lesions by small intestine radiography, [[esophagogastroduodenoscopy]] (EGD), [[colonoscopy]], pancreatic [[ultrasound]], pelvic ultrasound, [[mammography]], and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome. | Screening for cancerous lesions by small intestine radiography, [[esophagogastroduodenoscopy]] (EGD), [[colonoscopy]], pancreatic [[ultrasound]], [[pelvic ultrasound]], [[mammography]], and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome. | ||
==Screening== | ==Screening== | ||
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by: | Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by: | ||
| Line 20: | Line 20: | ||
*[[Endoscopic ultrasound]] | *[[Endoscopic ultrasound]] | ||
*[[Magnetic resonance cholangiopancreatography]] (MRCP) | *[[Magnetic resonance cholangiopancreatography]] (MRCP) | ||
*Abdominal CT | *Abdominal [[CT]] | ||
*Pelvic ultrasound (annually) | *[[Pelvic ultrasound]] (annually) | ||
*Testicular ultrasound (annually) | *Testicular ultrasound (annually) | ||
*[[Mammography]] at ages 25, 30, 35, and 38 years, then every 2 years until age 50 years, then annually | *[[Mammography]] at ages 25, 30, 35, and 38 years, then every 2 years until age 50 years, then annually | ||
*Cervical Papanicolaou (Pap) | *Cervical Papanicolaou test ([[Pap test]]) (annually). | ||
*Annual physical examination that includes evaluation of the breasts, abdomen, pelvis, and testes should be | *Annual physical examination that includes evaluation of the [[breasts]], [[abdomen]], [[pelvis]], and [[testes]] should be performed by a physician | ||
*Annual complete blood count to check for anemia should be done | *Annual complete blood count ([[CBC]]) to check for anemia should be done | ||
== References == | == References == | ||
Revision as of 18:05, 16 September 2015
|
Peutz-Jeghers syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Peutz-Jeghers syndrome screening On the Web |
|
American Roentgen Ray Society Images of Peutz-Jeghers syndrome screening |
|
Risk calculators and risk factors for Peutz-Jeghers syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Screening for cancerous lesions by small intestine radiography, esophagogastroduodenoscopy (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, mammography, and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome.
Screening
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the hamartomas by:
Screening for cancerous lesions among patients with Peutz-Jeghers syndrome include the following:[1]
- Small intestine radiography (every 2 years)
- Esophagogastroduodenoscopy (every 2 years)
- Colonoscopy every 2 years
- Pancreatic ultrasound (annually)
- Endoscopic ultrasound
- Magnetic resonance cholangiopancreatography (MRCP)
- Abdominal CT
- Pelvic ultrasound (annually)
- Testicular ultrasound (annually)
- Mammography at ages 25, 30, 35, and 38 years, then every 2 years until age 50 years, then annually
- Cervical Papanicolaou test (Pap test) (annually).
- Annual physical examination that includes evaluation of the breasts, abdomen, pelvis, and testes should be performed by a physician
- Annual complete blood count (CBC) to check for anemia should be done